RhythMed
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Pharmacokinetic Studies, Behavior Monitoring, Blood Sampling, Detailed Sleep Pattern Investigation, Eeg Analysis, Glucose Tolerance Testing |
| Founded | 2010 |
| Employees | 1-10 |
Key Contact at RhythMed
Janna V Arbuzova
Research Scientist and Co-founder
About RhythMed
RhythMed, LLC provides outstanding research support in the unique fields of sleep and circadian biology to pharmaceutical and biotechnology industries worldwide. With two locations in Illinois and Wisconsin we have the capability to offer a number of chemical and biological services with detailed analytical reporting to accommodate your needs. RhythMed offers state-of-the-art service to leading pharmacology and biotechnology companies. We specialize in screening new drugs and compounds targeting sleep and the circadian system. We use the latest and most sophisticated data acquisition systems (Pinnacle Technologies, Inc.) available on the market to monitor electroencephalograph (EEG) and electromyograph (EMG) recordings along with Stanford Software Systems for analysis of long-term circadian rhythm activity.
RhythMed revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
RhythMed has never raised funding before.
United Kingdom
Australia
Germany
South AfricaFrequently asked questions
4.8
40,000 users
